Literature DB >> 25281259

Diagnosis and management of langerhans cell histiocytosis.

Matthew R DiCaprio, Timothy T Roberts.   

Abstract

Langerhans cell histiocytosis is a rare group of disorders without a well-understood etiology. Known formerly as histiocytosis X, the disease has a wide spectrum of clinical presentations, including eosinophilic granuloma (solitary bone lesion), diabetes insipidus, and exophthalmos. It is also known by several eponyms, including Hand-Schüller-Christian disease when it manifests as a triad of cranial bone lesions and Letterer-Siwe disease when it is found in infantile patients with severely disseminated disease. Children aged 5 to 15 years are most commonly affected. Many of these patients initially present to orthopaedic surgeons, and misdiagnosis is frequent. To accurately diagnosis and treat these patients, the orthopaedic surgeon must be familiar with the clinical manifestations and pathophysiology of the disease as well as the treatment guidelines and outcomes for Langerhans cell histiocytosis. Copyright 2014 by the American Academy of Orthopaedic Surgeons.

Entities:  

Mesh:

Year:  2014        PMID: 25281259     DOI: 10.5435/JAAOS-22-10-643

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  19 in total

1.  Primary Langerhans Cell Histiocytosis of the Extrahepatic Bile Duct Occurring in an Adult Patient

Authors:  Ifeyinwa E. Obiorah; Alicia Henao Velasquez; Bhaskar Kallakury; Metin Özdemirli
Journal:  Balkan Med J       Date:  2018-03-08       Impact factor: 2.021

2.  [Recurrent vulvar rashes in a girl aged 22 months for more than half a year].

Authors:  Ke-Yao Li; Jian-Ping Tang; Yan-Ling Jiang; Xin Tan; Zhu Wei; Rong Wen; Bin Zhou
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

3.  Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.

Authors:  Georgi Iskrov; Itziar Astigarraga; Rumen Stefanov; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Arrigo Schieppati; Domenica Taruscio; Márta Péntek; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Karine Chevreul; Ulf Persson; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-04

4.  [Painful erosions, crusts, and papules in a 70-year-old woman].

Authors:  Fiona Koch; Sandra Hallasch; Nina Giese; Eva Hadaschick; Joachim Dissemond
Journal:  Hautarzt       Date:  2020-03       Impact factor: 0.751

Review 5.  Childhood Langerhans cell histiocytosis: a disease with many faces.

Authors:  Alexander K C Leung; Joseph M Lam; Kin Fon Leong
Journal:  World J Pediatr       Date:  2019-08-28       Impact factor: 2.764

6.  Resolution and Re-ossification of Orbital-Wall Langerhans Cell Histiocytosis Following Stereotactic Needle Biopsy.

Authors:  William C Broaddus; Aravind Somasundaram; Matthew T Carr; Charles F Opalak; Hope T Richard; Sharon B Wolber; Hayri E Sangiray
Journal:  J Neurol Surg Rep       Date:  2022-07-19

7.  Radiologic findings that aid in the reduction of misdiagnoses of Langerhans cell histiocytosis of the bone: a retrospective study.

Authors:  Mimi Zhao; Limin Tang; Shiqing Sun; Jiufa Cui; Haisong Chen
Journal:  World J Surg Oncol       Date:  2021-05-10       Impact factor: 2.754

8.  The surgical strategy for eosinophilic granuloma of the pediatric cervical spine complicated with neurologic deficit and/or spinal instability.

Authors:  Nanzhe Zhong; Wei Xu; Tong Meng; Xinghai Yang; Wangjun Yan; Jianru Xiao
Journal:  World J Surg Oncol       Date:  2016-12-07       Impact factor: 2.754

9.  Spontaneous remission of eosinophilic granuloma of the maxilla after incisional biopsy: a case report.

Authors:  Alex Vargas; Hernán Ramírez; Pablo Ramírez; Camila Foncea; Bernardo Venegas; Paula Astorga
Journal:  Head Face Med       Date:  2016-06-02       Impact factor: 2.151

10.  Pericardial Effusion in Langerhans Cell Histiocytosis: A Case Report.

Authors:  Narges Gholami
Journal:  Iran Red Crescent Med J       Date:  2016-05-10       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.